Clinicoanamnestic risk factors of mixed urinary incontinence in women

封面


如何引用文章

全文:

详细

Diagnosis of mixed urinary incontinence (UI) in women is a challenge for physicians in clini-cal practice. Objectives: The determination risk factors of mixed urinary incontinence in women Materials and Methods: The subjects were 633 women 22-88 years old with complaints of mixed (n = 356) and stress (n = 277) UI. Data of the history and clinical examination data were analyzed. For statistical data analysis t-test, chi-square (χ2) test was used. Results: Significant differences in the number of pregnancies and births, body mass index (BMI), the number of patients with concomitant pelvic organ prolapse (POP) between the groups of women with complaints of mixed stress and UI were not found. Clinicoanamnestic risk factors mixed UI in women compared with stress UI are older than 56 years (OR 1,67; 95 % CI1,2-2,36; p < 0,05), postmenopause ( OR 1,59; 95 % CI1,15-2,22; p < 0,05), medical comorbidity: hypertension (OR 1,99; 95 % CI1,43-2,76; p < 0,001), chronic cystitis (OR 1,85; 95 % CI1,1-3,1; p < 0,05), diabetes mellitus (OR 1,86; 95 % CI1,1-3,23; p < 0,05), ischemic heart disease (OR 2,13; 95 % CI1,5-3,0; p < 0,001), vascular lesions of the brain (OR 3,62; 95 % CI1,7-7,6; p < 0,001), neurological diseases (Parkinson’s, multiple sclerosis, myasthenia gravis) (OR 7,1; 95 % CI1,0-56,8; p < 0,05), surgery for pelvic organ prolapse (OR 3,12; 95 % CI1,25-7, 77; p < 0,05) and urinary incontinence history (OR 6,05; 95 % CI1,37-26,7; p < 0,01). Conclusions: Medical comorbidity, previous surgery on the POP and UI, age older than 56 years are clinicoanamnestic risk factors mixed UI.

作者简介

Elena Rusina

D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS

Email: pismo_rusina@mail.ru
PhD. Assistant professor of Operative Gynecology Department

参考

  1. Аль-Шукри С. Х., Кузьмин И. В. Симптоматика, клиническое течение и лечение гиперактивности мочевого пузыря у женщин. Гинекология. 2008; 10 (4): 78-80.
  2. Аполихина И. А. Клиническая эпидемиология, дифференциальная диагностика и консервативное лечение недержания мочи у женщин. Автореф. дис… д-ра мед. наук. М.; 2006.
  3. Петрова В. Д. Недержание мочи у женщин (этиопатогенез, клиника, диагностика, лечение). Автореф. дис… д-ра мед. наук. М.; 2005.
  4. Русина Е. И. Роль комплексного уродинамического исследования при планировании оперативного лечения у континентных женщин с пролапсом тазовых органов. Журнал акушерства и женских болезней. 2014; LXIII (1): 17-25.
  5. Русина Е. И., Беженарь В. Ф., Иващенко Т. Э., Пакин В. С., Баранов В. С. Особенности полиморфизма генов MMP1, ММP3, PAI1 у больных с пролапсом тазовых органов и стрессовым недержанием мочи. Акушерство и гинекология. 2014; 9: 63-8.
  6. Шварц П. Г. Нейрогенные нарушения мочеиспускания у больных с острыми и хроническими сосудистыми заболеваниями головного мозга (клиника, диагностика и лечение). Автореф. дис… д-ра мед. наук. М.; 2013.
  7. Botlero R, Davis SR, Urquhart DM, Bell RJ. Incidence and resolution rates of different types of urinary incontinence in women: findings from a cohort study. J. Urol. 2011; 185 (4): 1331-7.
  8. Brown J. S., Jackson R. A., Kanaya A. M. Urinary incontinence in elderly women: The health, aging and body composition study. 2-nd International Consultation on Incontinence: abstract. Paris; 2001: 24.
  9. Campeau L, Gorbachinsky I, Badlani G.H, Andersson K. E. Pelvic floor disorders: linking genetic risk factors to biochemical changes. BJU Int. 2011; 108 (8): 1240-7.
  10. Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst. Rev. 2012;17 (10): CD001405.
  11. Elbadawi A., Yalla S. V., Resnick N. M. Structural basis of geriatric voiding dysfunction. I. Methods of a prospective ultrastructural/urodynamic study, and an overview of the findings. J. Urol. 1993; 150 (5 Pt2): 1650-6.
  12. Frick A. C., Huang A. J., Van den Eeden S. K., Knight S. K., Creasman J. M., Yang J., Ragins A. I., Thom D. H., Brown J. S. Mixed urinary incontinence: greater impact on quality of life. J. Urol. 2009; 182 (2): 596-600.
  13. Hannestad Y. S., Rortveit G., Sandvik H., Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J. Clin. Epidemiol. 2000; 53 (11): 1150-7.
  14. Khullar V., Sexton C. C., Thompson C. L., Milsom I., Bitoun C. E., Coyne K. S. The relationship between BMI and urinary incontinence subgroups: results from EpiLUTS. Neurourol. Urodyn. 2014; 33 (4): 392-9.
  15. Kim H., Yoshida H., Suzuki T. Risk factors associated with urinary incontinence in community-dwelling elderly women. Nippon Ronen Igakkai zasshi. 2008; 45 (3): 315-22.
  16. Ohlsson B. L., Fall M., Frankenberg-Sommar S. Effects of external and direct pudendal nerve maximal electrical stimulation in the treatment of the uninhibited overactive bladder. Br. J. Urol. 1989; 64 (4): 374-80.
  17. Parazzini F., Chiaffarino F., Lavezzari M., Giambanco V. Risk factors for stress, urge or mixed urinary incontinence in Italy.Br. J. Obst. Gynaecol. 2003; 110 (10): 927-33.
  18. Strasser H., Tiefenthaler M., Steinlechner M., Eder I., Bartsch G., Konwalinka G. Age dependent apoptosis and loss of rhabdosphincter cells. J. Urol. 2000; 164 (5): 1781-5.
  19. Subak L. L., Wing R., West D. S., Franklin F., Vittinghoff E. Creasman J. M., Richter H. E., Myers D., Burgio K. L., Gorin A. A. Macer J., Kusek J. W., Grady D. Weight loss to treat urinary incontinence in overweight and obese women. Engl. J. Med. 2009; 360 (5): 481-90.
  20. Zhang W., Song Y., He X., Huang H., Xu B., Song J. Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women. Neurourol. Urodyn. 2006; 25 (7): 717.

版权所有 © Rusina E.I., 2015

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

##common.cookie##